Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: Development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia

Annals of the New York Academy of Sciences

Volumn 996, Issue , 2003, Pages 17-25

  Ballmaier, Matthias ^a   Germeshausen, M ^a   Krukemeier, S ^a   Welte, K ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Aplastic anemia; C mpl; Congenital amegakaryocytic thrombocytopenia; Thrombopoietin

Indexed keywords

GENE PRODUCT; PROTEIN C MPL; THROMBOPOIETIN; UNCLASSIFIED DRUG;

APLASTIC ANEMIA; BONE MARROW CELL; C MPL GENE; CONFERENCE PAPER; CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEGAKARYOCYTE; NONHUMAN; ONCOGENE; PROTEIN FUNCTION; STEM CELL; THROMBOCYTE; THROMBOCYTOPENIA;

EID: 0038129842     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03228.x     Document Type: Conference Paper

References (21)

1. O'GORMAN HUGHES, D. 1974. Aplastic anemia in childhood. III. Constitutional aplastic anaemia and related cytopenias. Med. J. Austr. 1: 519.
2. FREEDMAN, M.H. & Z. ESTROV. 1990. Congenital amegakaryocytic thrombocytopenia: an intrinsic hematopoietic stem cell defect. Am. J. Pediatr. Hematol. Oncol. 12: 225-230.
3. BALLMAIER, M. et al. 2001. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood 97: 139-46.
4. IHARA, K. et al. 1999. Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc. Natl. Acad. Sci. USA 96: 3132-3136.
5. BALLMAIER, M. et al. 1999. Defective TPO-reactivity in congenital amegakaryocytic thrombocytopenia [abstract]. Blood 94: 44a.
6. VAN DEN OUDENRIJN, S. et al. 2000. Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia. Br. J. Haematol. 110: 441-448.
7. TONELLI, R. et al. 2000. Compound heterozygosity for two different amino-acid substitution mutations in the thrombopoietin receptor (c-mpl gene) in congenital amegakaryocytic thrombocytopenia (CAMT). Hum. Genet. 107: 225-233.
8. VAN DEN OUDENRIJN, S. et al. 2002. Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia. Br. J. Haematol. 117: 390-398.
9. ALTER, B.P. & N.S. YOUNG. 1998. The bone marrow failure syndromes. In Nathan and Oski's Hematology of Infancy and Childhood, 5th ed. D.G. Nathan & S.H. Orkin, Eds. W.B. Saunders. Philadelphia, PA.
10. KU, H. et al. 1996. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 87: 4544-4551.
11. SITNICKA, E. et al. 1996. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood. 87: 4998-5005.
12. KOBAYASHI, M. et al. 1996. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood 88: 429-436.
13. - bone marrow cells with multilineage potential at the single-cell level: Key role of thrombopoietin. Blood 90: 2282-2292.
14. CARVER-MOORE, K. et al. 1996. Low levels of erythroid and myeloid progenitors in thrombopoietin- and c-mpl-deficient mice. Blood 88: 803-808.
15. Fox, N. et al. 2002. Thrombopoietin expands hematopoietic stem cells after transplantation. J. Clin.. Invest. 110: 389-394.
16. METCALF, D. 1998. The molecular control of hematopoiesis: progress and problems with gene manipulation. Stem Cells 16(Suppl 2): 1-9.
17. LI, J. et al. 2001. Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 98: 3241-3248.
18. BASSER, R.L. et al. 2002. Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood 99: 2599-2602.
19. VAN DEN OUDENRIJN, S., M. DE HAAS & A.E. VON DEM BORNE. 2001. Screening for c-mpl mutations in patients with congenital amegakaryocytic thrombocytopenia identifies a polymorphism. Blood 97: 3675-3676.
20. BALLMAIER, M., M. GERMESHAUSEN & K. WELTE. 2001. Response: screening for c-mpl mutations in patients with congenital amegakaryocytic thrombocytopenia identifies a polymorphism. Blood 97: 3676.
21. LUBIN, B.H. 1993. Reference values in infancy and childhood. In Hematology of Infancy and Childhood, 4th ed. D.G. Nathan & F.A. Oski, Eds. W.B. Saunders. Philadelphia, PA.